Perfil
Saeed Motahari served as the President, Chief Executive Officer & Director at INSYS Therapeutics, Inc. from 2017 to 2019.
Prior to that, he worked as the Chief Commercial Officer at Purdue Pharma LP.
He also worked as a Principal at AbbVie, Inc. Mr. Motahari received his undergraduate and graduate degrees from Concordia University.
Antiguos cargos conocidos de Saeed Motahari.
| Empresas | Cargo | Fin |
|---|---|---|
| INSYS THERAPEUTICS, INC. | Director Ejecutivo | 14/04/2019 |
| ABBVIE INC. | Corporate Officer/Principal | - |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | - |
Formación de Saeed Motahari.
| Concordia University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
- Bolsa de valores
- Insiders
- Saeed Motahari
